Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi Consumer Healthcare India Ltd

₹ 5,105 -0.46%
21 May 12:31 p.m.
sanofi.in BSE: 544250 NSE: SANOFICONR
About
[ add key points ]
Website BSE NSE
  • Market Cap ₹ 11,757 Cr.
  • Current Price ₹ 5,105
  • High / Low ₹ 5,499 / 4,212
  • Stock P/E 62.7
  • Book Value ₹ 119
  • Dividend Yield 1.08 %
  • ROCE 111 %
  • ROE 83.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 43.4 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
210 160 222 164 160 171 173
116 97 140 101 97 109 109
Operating Profit 95 63 82 64 63 62 64
OPM % 45% 39% 37% 39% 39% 36% 37%
1 3 3 -24 3 2 5
Interest 0 3 0 0 3 0 0
Depreciation 1 2 1 1 2 1 2
Profit before tax 95 61 84 39 61 63 67
Tax % 25% 26% 25% 25% 26% 29% 25%
71 45 63 29 45 44 50
EPS in Rs 12.59 19.54 19.24 21.71
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2023 8m Dec 2024 TTM
555 724 668
337 454 415
Operating Profit 219 271 253
OPM % 39% 37% 38%
2 -15 -13
Interest 0 4 4
Depreciation 2 4 6
Profit before tax 219 247 230
Tax % 25% 27%
165 181 168
EPS in Rs 78.59 73.08
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 30%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 21%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 84%

Balance Sheet

Figures in Rs. Crores

Dec 2023 Dec 2024
Equity Capital 2 23
Reserves 206 250
0 20
138 138
Total Liabilities 345 431
5 29
CWIP 3 1
Investments 0 0
338 402
Total Assets 345 431

Cash Flows

Figures in Rs. Crores

Dec 2023 Dec 2024
-0 439
0 2
2 -116
Net Cash Flow 2 325

Ratios

Figures in Rs. Crores

Dec 2023 Dec 2024
Debtor Days 21 7
Inventory Days 232 80
Days Payable 144 138
Cash Conversion Cycle 109 -51
Working Capital Days 134 -31
ROCE % 111%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025
60.40% 60.40% 60.40% 60.40%
6.03% 5.22% 4.42% 4.52%
22.60% 23.83% 25.35% 25.48%
10.98% 10.56% 9.84% 9.59%
No. of Shareholders 61,09158,58255,73451,859

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports